Pharma

Your Article Summary

See Latest Articles

Excellent Performance Highlights Second Quarter for Bristol-Myers Squibb
Bristol Myers-Squibb Company, 07/24/09

Bristol–Myers Squibb Company reported sales and earnings growth for the second quarter 2009. "The excellent results for the second quarter and first six months of the year clearly represent how Bristol–Myers Squibb is rapidly transforming into a next–generation BioPharma leader through robust science, superior operational performance and disciplined financial management," said James M. Cornelius, chairman and chief executive officer. "We are well on–track to continue delivering on our growth commitments.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Report: Acquisition Activity Down
HealthDataManagement, 12/08/09

Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09

Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09

 See all of Financial Reports